Serai Pharma Healthcare Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
- Paid Up Capital ₹ 9.28 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 10.77%
- Profit Growth 134.22%
- Ebitda 110.15%
- Net Worth 1.66%
- Total Assets -12.00%
About Serai Pharma Healthcare Solutions
Serai Pharma Healthcare Solutions Private Limited (SPHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2019 (Five years and ten months 7 days old ). Its registered office is in Communication, Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 9.28 M, as per Ministry of Corporate Affairs (MCA) records.
Kishore Serai, Neelam Devani, and Rahul Rizwani serve as directors at the Company.
Company Details
- Location
Communication, Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2019PTC324320
- Company No.
324320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Serai Pharma Healthcare Solutions?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishore Serai  | Director | 06-Jan-2020 | Current |
| Neelam Devani | Director | 20-Apr-2019 | Current |
| Rahul Rizwani | Director | 20-Apr-2019 | Current |
Financial Performance of Serai Pharma Healthcare Solutions.
Serai Pharma Healthcare Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.77% increase. The company also saw a substantial improvement in profitability, with a 134.22% increase in profit. The company's net worth moved up by a moderate rise of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serai Pharma Healthcare Solutions?
In 2023, Serai Pharma Healthcare Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Serai Pharma Healthcare Solutions?
Unlock and access historical data on people associated with Serai Pharma Healthcare Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serai Pharma Healthcare Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serai Pharma Healthcare Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.